Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method of treating HER2-positive breast cancers with selective androgen receptor modulators (SARMS)

Method of treating HER2-positive breast cancers with selective androgen receptor modulators (SARMS)

US Patent 10314807 · Granted Jun 11, 2019

Estimated economic value: $3,953,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Polymorphs of [2-(1H-indol-3-yl)-1H-imidazol-4- yl] (3,4,5-trimethoxyphenyl)meth2025
Selective androgen receptor degrader (SARD) ligands and methods of use thereof2025
Selective androgen receptor degrader (SARD) ligands and methods of use thereof2025
Selective androgen receptor degrader (SARD) ligands and methods of use thereof2024
Selective androgen receptor degrader (SARD) ligands and methods of use thereof2024
Treatment of skeletal-related events for breast cancer patients2024
Treatment of skeletal-related events for breast cancer patients2024
Treatment of skeletal-related events for breast cancer patients2024
Treatment of skeletal-related events for breast cancer patients2024
Solid forms of selective androgen receptor modulators2024
Selective androgen receptor degrader (SARD) ligands and methods of use thereof2024
Selective androgen receptor degrader (SARD) ligands and methods of use2023